By Friday, the market was already trying to price in a fragile peace.

By Sunday, that illusion looked a lot weaker.

Weekend talks between the U.S. and Iran in Islamabad ended without a deal. President Trump then said the U.S. would move toward blockading the Strait of Hormuz, while Iran’s Revolutionary Guards warned that military vessels approaching the strait would be treated as a ceasefire breach. Markets responded by turning more cautious, with Gulf equities softening and the dollar catching a safe-haven bid.

That matters, because last week’s winners were not the kind of stocks investors pile into when everything feels safe.

They were the names tied to real bottlenecks, real policy relief, and hard-to-replace capacity.

That is the real message of this market right now.

It is still paying for scarcity.

But now it wants proof.

Two weeks ago, we were talking about a market that was rewarding scarcity in a broad sense. Energy. Electricity. Industrial choke points. Hard assets. This week, that same idea got sharper. Scarcity by itself was no longer enough. The winners were the companies where investors could see a direct path from scarcity to earnings power, pricing leverage, policy support, or strategic necessity.

That is why leadership stayed concentrated.

This was not a broad risk-on chase.

It was a selective repricing.

The weekend collapse in U.S.-Iran talks did not change the market’s message. It clarified it. Investors are still paying for scarcity, but only where that scarcity comes with proof.

If the market believed the macro clouds had cleared, money would have rushed back into everything.

It did not.

Instead, capital concentrated in a narrower set of themes that all shared one characteristic. They mattered even if the macro stayed messy.

AI compute and chip chain names remained among the strongest performers. The market kept rewarding the businesses closest to constrained compute, connectivity, packaging, and test capacity. That is important because the semiconductor story is no longer just about AI excitement. It is about real infrastructure, real capacity, and real strategic importance, especially as the U.S. keeps pressure on advanced chip and equipment flows tied to China.

Industrial buildout and power infrastructure names also stayed strong. That makes sense. If AI is the headline, power quality, cooling, electrical distribution, and industrial support remain the toll roads underneath it. These are the companies that benefit from physical buildout, not just digital narrative.

Healthcare may have been the most important new development in the entire report. This was not random biotech enthusiasm. The government finalized a much better than expected 2027 Medicare Advantage payment increase, materially improving the outlook for insurers and related healthcare names. Reuters reported the finalized rate at 2.48%, far above the near-flat proposal from January, with total payment growth closer to 5% after the risk-score adjustment is included.

Hard assets and critical materials also held up better than many expected. Even with oil falling sharply on ceasefire hopes earlier in the week, the market did not fully abandon strategic materials or system hedges. China’s central bank extended its gold-buying streak to 17 straight months in March, a reminder that institutional demand for real assets remains alive beneath the surface.

There was also the usual speculative outlet. Crypto beta names joined the move as investors leaned back into selective risk. But I would not treat that group as the centerpiece. It was more of a pressure valve than the main message.

The bigger message is that capital got choosier.

It paid up for what it trusted.

If you have been reading these reports over the past few weeks, the continuity should be obvious.

We have been tracking a market that keeps circling back to scarcity. Not because scarcity sounds dramatic. Because scarcity is where pricing power and opportunity tend to show up first when the macro gets harder to read.

That is still true.

But now the market is demanding something more. It wants evidence that scarcity can actually be monetized.

Not every tight market matters.

Not every overlooked asset matters.

Not every rebound matters.

The ones that matter now are the ones that can prove it.

That is why AI infrastructure kept leading. That is why industrial and electrical names stayed strong. That is why healthcare suddenly woke up. And that is why the insider signals that matter most this week are not necessarily the biggest in dollar terms, but the ones that showed up where capital was already starting to rotate.

If I had to pick the freshest and most important development in this week’s report, it would be healthcare.

The Medicare Advantage decision changed the narrative in a single stroke.

For years, this group has had to wrestle with rising medical costs, squeezed margins, and persistent regulatory anxiety. Then the government finalized a much stronger payment rate than the market expected. That gave investors something concrete to work with. Not hope. Not a story. Not a turnaround promise.

A real release valve.

And once that happened, the stocks moved.

That is where this week’s most important insider signal enters the picture.

Oscar Health was one of the clearest examples of the shift. It showed up among the week’s strongest gainers just as the policy picture improved. Then CEO Mark Bertolini stepped in with a purchase of roughly $11.9 million worth of stock.

That is meaningful.

To be precise, this was not the cleanest plain-vanilla open-market buy in the file. It came through a mixed filing. But it was still a genuine purchase of 1,000,000 shares at $11.92, and it landed right as the market was beginning to reprice a real healthcare policy shift. That is exactly the kind of insider behavior I care about. Not because it sounds exciting, but because it shows management leaning in while the market is just starting to recognize the setup.

That makes healthcare the emotional center of this week’s report.

Not because it was the only group that worked.

Because it was the clearest example of the market demanding proof, then immediately rewarding the companies that got it.

Everyone already knows AI is a big story.

That is not the interesting part anymore.

The interesting part is where the market keeps choosing to express that theme.

This week it was not vague AI narratives or concept stocks. It was the names closest to constrained capacity and enabling infrastructure. Test equipment. Optical components. Connectivity. Packaging. Critical chip-adjacent plumbing.

That matters because semiconductor infrastructure remains strategic, political, and constrained. The recent export-control backdrop reinforces that reality and keeps pushing investors toward the parts of the stack that are hardest to replicate.

The market understands that.

Which is why it keeps rewarding the toll roads.

The same logic applies to industrial and power infrastructure. If AI is the headline, power quality, cooling, electrical distribution, and industrial support remain the hidden foundation. The market is still willing to pay for the businesses that make the system work.

Again, scarcity.

But now with proof.

A lot of people will look at last week’s oil collapse and assume the hard-asset trade disappeared.

I do not think that is right.

What disappeared, briefly, was the panic premium.

That is different.

Underneath the surface, investors are still showing respect for strategic materials, real assets, and supply chains that matter if the global system stays fragile. Gold may have cooled, but central-bank accumulation has not gone away. Seventeen straight months of buying from China’s central bank is not noise. It is a reminder that even when the market gets excited about relief, serious money still wants exposure to things that cannot be printed, replicated quickly, or replaced easily.

That helps explain why names tied to mining, metals, and strategic materials continued to show up among the winners.

It is not the main story this week.

But it is still part of the same larger story.

This is where the report gets more useful.

Insider buying helps separate an interesting market theme from an actionable one.

And after checking the filings carefully, a few things stand out.

First, not every buy should be treated the same way.

Some of the names in this week’s insider file were clean, plain-vanilla purchases. Others came through mixed filings that also included grants, vesting, or other compensation-related items. That does not make them useless. It just means the wording has to be accurate.

The cleanest, most straightforward purchases among the names we reviewed were H.B. Fuller, Acuity, Taiwan Semiconductor, Nike, Victoria’s Secret, and Sibanye Stillwater.

H.B. Fuller’s CEO, Celeste Beeks Mastin, bought 5,170 shares for about $295,000.

Acuity director Laura O’Shaughnessy bought 1,000 shares for about $283,000.

Taiwan Semiconductor director Ursula Burns bought 1,000 ADS for about $322,000, reinforcing the chip-capacity theme.

Learn How I Find And Use Insider Information Here

Nike saw two clean director buys after a bruising reset in sentiment.

Victoria’s Secret also saw multiple director purchases.

Sibanye Stillwater had officer buying, which keeps it relevant to the hard-asset and materials side of the story.

Those are the kinds of signals I like because the paper trail is cleaner and the intent is easier to interpret.

Then there are the names where the filing is still useful, but the wording needs to be more careful.

Oscar Health belongs in that category.

So does WESCO.

So does Vale.

The point is not to pretend every filing is perfect.

The point is to focus on where the buying is both real and relevant.

This week, the best insider signals are the ones that line up with the themes the market is already rewarding.

That is why Oscar matters.

That is why Taiwan Semiconductor matters.

That is why Acuity, H.B. Fuller, and WESCO matter.

And that is why some of the consumer-related names, while interesting, still look more like early-repair candidates than confirmed leadership.

We do not chase everything that moved.

We do not assume every sharp rebound is durable.

And we do not confuse a temporary ceasefire headline with a full reset in the market.

Instead, we keep doing what works.

We follow the capital.

We track where leadership is staying concentrated.

And we pay very close attention when insiders step in where the market is already starting to reward something real.

That is the entire point of this report.

This week’s winners were not random.

They told us the market still wants scarcity.

But only the kind that can prove itself.

Going into next week, I will be focused on four things.

First, I want to see whether AI and chip infrastructure leadership broadens or narrows. If the bottleneck names keep working while weaker narratives fade, that will be another sign that this market still wants proof.

Second, I want to see whether healthcare follow-through continues after the Medicare Advantage surprise. One good week is a reaction. A second wave of buying would tell us something more important.

Third, I want to see whether industrial and power-adjacent names keep acting like toll roads rather than just rebound trades.

And fourth, I want to see where insider conviction shows up next, especially in the names that have not fully moved yet, but where the filings suggest management or directors see a disconnect the market has not completely closed.

That is where the real signal tends to be.